Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

This is a new position for Foresite Capital Management IV, LLC, representing 13.8% of reportable assets under management as ...

Spyre Therapeutics (SYRE) has strong technical momentum and is trading at a new 52 week high. ・SYRE maintains a 100% “Buy” ...

John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

When visionary entrepreneur and investor David Roja joined The Rhonda Swan Show: Wake Up New York City Edition on Wall Street ...

Evercore 8th Annual Healthcare Conference December 3, 2025 2:35 PM ESTCompany ParticipantsSteven Harr - President, CEO ...

Aether Biomachines use an AI process to identify novel materials, then build them with biotechnology. They are the first ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if ...

Recently, The Kuni Foundation sponsored a conversation with the Portland Business Journal about the challenges and ...